Karyopharm Therapeutics Inc. (KPTI) stock
KPTINasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPTIQ
$0.35−0.04 (-11.30%)
Close on Oct 19, 2026Market cap $10.01KP/E –Yield –
Karyopharm Therapeutics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Karyopharm Therapeutics's shares outstanding was 0M at Jun 30, 2026. For fiscal 2025 it was 0M, up 29.3% from the year before. Over ten years it grew -41.6% a year on average. The highest annual figure on record is 5M in fiscal 2021.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0M | +29.3% |
| FY2024 | Dec 31, 2024 | 0M | +11.0% |
| FY2023 | Dec 31, 2023 | 0M | +39.5% |
| FY2022 | Dec 31, 2022 | 0M | -99.9% |
| FY2021 | Dec 31, 2021 | 5M | +4.4% |
| FY2020 | Dec 31, 2020 | 5M | +16.3% |
| FY2019 | Dec 31, 2019 | 4M | +109023.7% |
| FY2018 | Dec 31, 2018 | 0M | -99.9% |
| FY2017 | Dec 31, 2017 | 3M | +22.3% |
| FY2016 | Dec 31, 2016 | 3M | +5.3% |
| FY2015 | Dec 31, 2015 | 2M | +14.4% |
| FY2014 | Dec 31, 2014 | 2M | +413.1% |
| FY2013 | Dec 31, 2013 | 0M | +241.8% |
| FY2012 | Dec 31, 2012 | 0M | +76.8% |
| FY2011 | Dec 31, 2011 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 0M | +235.7% |
| Q1 FY2026 | Mar 31, 2026 | 0M | +191.8% |
| Q4 FY2025 | Dec 31, 2025 | 0M | +111.7% |
| Q3 FY2025 | Sep 30, 2025 | 0M | +4.0% |
| Q2 FY2025 | Jun 30, 2025 | 0M | -16.3% |
| Q1 FY2025 | Mar 31, 2025 | 0M | +10.0% |
| Q4 FY2024 | Dec 31, 2024 | 0M | +10.9% |
| Q3 FY2024 | Sep 30, 2024 | 0M | +9.3% |
| Q2 FY2024 | Jun 30, 2024 | 0M | -99.9% |
| Q1 FY2024 | Mar 31, 2024 | 0M | -99.9% |
| Q4 FY2023 | Dec 31, 2023 | 0M | -99.9% |
| Q3 FY2023 | Sep 30, 2023 | 0M | -99.9% |
| Q2 FY2023 | Jun 30, 2023 | 8M | +47.2% |
| Q1 FY2023 | Mar 31, 2023 | 8M | +50.0% |
| Q3 FY2022 | Sep 30, 2022 | 5M | +6.3% |
| Q2 FY2022 | Jun 30, 2022 | 5M | +5.9% |
| Q1 FY2022 | Mar 31, 2022 | 5M | +4.1% |
| Q4 FY2021 | Dec 31, 2021 | 5M | +2.6% |
| Q3 FY2021 | Sep 30, 2021 | 5M | +2.7% |
| Q2 FY2021 | Jun 30, 2021 | 5M | +2.7% |
| Q1 FY2021 | Mar 31, 2021 | 5M | +110099.6% |
| Q4 FY2020 | Dec 31, 2020 | 5M | +15.3% |
| Q3 FY2020 | Sep 30, 2020 | 5M | +118202.7% |
| Q2 FY2020 | Jun 30, 2020 | 5M | +120098.6% |
| Q1 FY2020 | Mar 31, 2020 | 0M | +11.1% |
| Q4 FY2019 | Dec 31, 2019 | 4M | +5.5% |
| Q3 FY2019 | Sep 30, 2019 | 0M | -99.9% |
| Q2 FY2019 | Jun 30, 2019 | 0M | -99.9% |
| Q1 FY2019 | Mar 31, 2019 | 0M | -99.9% |
| Q3 FY2018 | Sep 30, 2018 | 4M | +28.5% |
| Q2 FY2018 | Jun 30, 2018 | 4M | +22.4% |
| Q1 FY2018 | Mar 31, 2018 | 3M | +18.4% |
| Q4 FY2017 | Dec 31, 2017 | 3M | +17.5% |
| Q3 FY2017 | Sep 30, 2017 | 3M | +28.0% |
| Q2 FY2017 | Jun 30, 2017 | 3M | – |
| Q1 FY2017 | Mar 31, 2017 | 3M | – |
| Q4 FY2016 | Dec 31, 2016 | 3M | – |
| Q3 FY2016 | Sep 30, 2016 | 2M | – |
See a number that looks wrong?